Ordinarily, the lambda virus grabs onto a particular protein on E. coli’s surface with a matching receptor of its own, then uses that attachment to enter the bacterial cell. By growing E. coli under restrictive conditions, however, Meyer and his colleagues created a strain in which that surface protein was almost completely absent, making infection nearly impossible. One might expect that the lambda virus would rapidly die out in that culture.(via)
Instead, the researchers found that in 24 out of 96 cultures, the viruses evolved an unprecedented ability to infect E. coli via a completely different surface protein — and in just 15 days. Analysis revealed that they managed this transition with just four small mutations.
Part of what makes this adaptation remarkable, as John N. Thompson of the University of California, Santa Cruz, observed in a commentary accompanying Meyer’s paper, is that it defies intuitions about how evolution works:
One of the great metaphors of evolutionary biology … is that populations evolve toward adaptive peaks separated by adaptive valleys. The peaks are combinations of genes that confer high Darwinian fitness on individuals, whereas the valleys are combinations that confer low fitness. But how can a population move from one peak to another, perhaps higher, peak, across an adaptive valley in which gene combinations are presumed to be maladaptive?In this case, the answer is in how the bacterium and the virus evolved together.
Mutations in synergy
Lenski’s group looked in detail at the specific mutations that enabled the switch to the second protein. They only conferred that ability in combination: individually, they didn’t have any affinity for the second protein. Rather, they had affinities for the original surface protein.
That was the key. Although most of the new E. coli strain couldn’t make the original protein anymore, a very few had random mutations that restored that ability (it offered no survival advantage). The viral mutations were individually advantageous because on their own, they improved or sustained the virus’s ability to infect those few precious, vulnerable cells.
Wednesday, February 8, 2012
Watching Evolution do its thing in a petri dish
Subscribe to:
Post Comments (Atom)
Labels
5-AZA
A. Melvin Ramsay
Acne
Advocacy
Alan Light
Alternative medicine is an untested danger
Ampligen
Andrew Wakefield
Anecdote
Anthony Komaroff
Antibiotics
Antibodies
Anxiety
Aphthous Ulcers
Apnea
Asthma
Autism
Autoimmune Disease
Behçet’s
Ben Katz
Bertrand Russell
Biology
Blood sugar
Bruce Carruthers
Caffeine
Calcium
Cancer
Capitalism
Cardiology
Carmen Scheibenbogen
CBT/GET
CDC
Celiac Disease
Cereal Grains
CFIDS
Chagas
Charité
Charles Lapp
Christopher Snell
Chronix
Clinician
Coconut Milk
Cognition
Common Sense and Confirmation Bias
Conversion Disorder
Coxiella Burnetii
Coxsackie
Criteria
Crohn's
Cushing's Syndrome
Cytokine
Daniel Peterson
Darwinism
David Bell
Depression
Diabetes
Diagnostic
Differential
Disease
Diseases of Affluence
DNA
DNA Sequencing
Dog
DSM5
EBV
EEG
Eggs
Elaine DeFreitas
Elimination Diet
Enterovirus
Epstein-Barr
ERV
Etiology
Evolution
Exercise Challenge
Faecal Transplant
Fame and Fraud and Medical Science
Fatigue
Fatty Acids
Fibromyalgia
Francis Ruscetti
Fructose
Gene Expression
Genetics
Giardia
Gordon Broderick
Gulf War Illness
Gut Microbiome
Harvey Alter
Health Care System
Hemispherx
Hemolytic Uremic Syndrome
Herpesviridae
High Blood Pressure
Historic Outbreaks
HIV
HPV
Hyperlipid
Ian Hickie
Ian Lipkin
Immune System
Infection
Intermittent Fasting
It's the environment stupid
Jacob Teitelbaum
Jamie Deckoff-Jones
Jo Nijs
John Chia
John Coffin
John Maddox
José Montoya
Judy Mikovits
Karl Popper
Kathleen Light
Kenny De Meirleir
Lactose
Lamb
Laszlo Mechtler
LCMV
Lecture
Leonard Jason
Leukemia
Life
Liver
Loren Cordain
Low Carb
Low-Dose Naltrexone (LDN)
Luc Montagnier
Lucinda Bateman
Ludicrous Notions
Lumpers and Splitters
Lyme
Mady Hornig
Mark Hasslett
Martin Lerner
Mary Schweitzer
MCS
ME/CFS
Medical Industry
Medicine is not based on anecdotes
Michael Maes
Migraine
Milk and Dairy
Mitochondria
MMR
Money and Fame and Fraud
MRI
Multiple Chemical Sensitivity
Multiple Sclerosis
Mutton
My Symptoms
n-1
Nancy Klimas
Narcolepsy
Neurodermitis
Neuroscience
NK-Cell
Nocebo
NSAID
Nutrition
Obesity
On Nutrition
Pain
Paleo
Parathyroid
Pathogen
Paul Cheney
PCR
Pharmaceutical Industry
Picornavirus
Placebo
Polio
Post Exertional Malaise
POTS/OI/NMH
PTSD
PUFA
Q Fever
Quote
Rare Disease
Research
Retrovirus
Rheumatoid Arthritis
Rituximab
RNA
Robert Gallo
Robert Lustig
Robert Silverman
Robert Suhadolnik
Rosario Trifiletti
Sarah Myhill
Sarcasm
Science
Sequencing
Seth Roberts
Shrinks vs. Medicine
Shyh-Ching Lo
Simon Wessely
Sinusitis
Sjögren's
Somnolence
Sonya Marshall-Gradisnik
Speculation
Stanislaw Burzynski
Statins
Stefan Duschek
Study
Sucrose
Sugar
Supplements
Symptoms
T1DM
T2DM
There is no such thing as Chronic Lyme
There is no such thing as HGRV
Thyroid
Tinitus
To Do
Toni Bernhard
Tourette's
Treatment
Tuberculosis
Vaccine
Video
Vincent Lombardi
Vincent Racaniello
Virus
Vitamin B
Vitamin D
VP62
When Evidence Based Medicine Isn't
Whooping Cough
Wolfgang Lutz
WPI
XMRV
You fail science forever
No comments:
Post a Comment
Comments are most welcome! But please:
- No SPAM whatsoever, no supplements, no pharmaceuticals, no herbs or any other advertisements
- Absolutely no quack-doctors pushing their quack-BS websites (and if you are a quack, I will call you out)
- Be critical if you want to, but try to be coherent
Comments are moderated, because I am tired of Gerwyn-V99-The-Idiot and his moronic sockpuppets, and tired of the story of the two dogs, but I will try to publish everything else.
If you are not Gerwyn (and want to tell me something other than the story of the two dogs), then relax and write something! :-)